Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme Suchitra Ella said the data of Phase 3 trials has been submitted to the Drug Controller General of India for its perusal and efficacy of the vaccine against many of the variants was also tested. Share Via Email | A+A A- A doctor administers Covaxin vaccine against the coronavirus during a vaccination for those above age 18 in Mumbai. (Photo | AP) By PTI HYDERABAD: Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the ...